Trinomab is building a robust pipeline using state-of-the-art fully native human monoclonal antibody science. The company is focused on developing innovative treatments that will benefit patients around the world.


Product code Indications Target Pre-clinical phase I phase 2 phase 3 Registration
TNM001 Prevention of RSV infection RSV Pre-F protein
TNM002 Prevention of tetanus Tetanus toxin
TNM005 Prevention and treatment of VZV infection VZV gH/gL protein
TNM006 hCMV infection (prevention) human cytomegalovirus
TNM009 Pain NGF
TNM030 Bacterial infectious shock Hla toxin
TNM039 Rabies prevention Rabies virus
Product code Indications Target Pre-clinical phase I phase 2 phase 3 Registration
TNM001 Prevention of RSV infection RSV Pre-F protein
TNM002 Prevention of tetanus Tetanus toxin
TNM005 Prevention and treatment of VZV infection VZV gH/gL protein
TNM006 hCMV infection (prevention) human cytomegalovirus
TNM009 Pain NGF
TNM030 Bacterial infectious shock Hla toxin
TNM039 Rabies prevention Rabies virus
Product code Indications Target Pre-clinical phase I phase 2 phase 3 Registration
TNM001 Prevention of RSV infection RSV Pre-F protein
TNM002 Prevention of tetanus Tetanus toxin
TNM005 Prevention and treatment of VZV infection VZV gH/gL protein
TNM006 hCMV infection (prevention) human cytomegalovirus
TNM009 Pain NGF
TNM030 Bacterial infectious shock Hla toxin
TNM039 Rabies prevention Rabies virus
Product code Indications Target Pre-clinical phase I phase 2 phase 3 Registration
TNM001 Prevention of RSV infection RSV Pre-F protein
TNM002 Prevention of tetanus Tetanus toxin
TNM005 Prevention and treatment of VZV infection VZV gH/gL protein
TNM006 hCMV infection (prevention) human cytomegalovirus
TNM009 Pain NGF
TNM030 Bacterial infectious shock Hla toxin
TNM039 Rabies prevention Rabies virus
Product code Indications Target Pre-clinical phase I phase 2 phase 3 Registration
TNM001 Prevention of RSV infection RSV Pre-F protein
TNM002 Prevention of tetanus Tetanus toxin
TNM005 Prevention and treatment of VZV infection VZV gH/gL protein
TNM006 hCMV infection (prevention) human cytomegalovirus
TNM009 Pain NGF
TNM030 Bacterial infectious shock Hla toxin
TNM039 Rabies prevention Rabies virus
Product code Indications Target Pre-clinical phase I phase 2 phase 3 Registration
TNM001 Prevention of RSV infection RSV Pre-F protein
TNM002 Prevention of tetanus Tetanus toxin
TNM005 Prevention and treatment of VZV infection VZV gH/gL protein
TNM006 hCMV infection (prevention) human cytomegalovirus
TNM009 Pain NGF
TNM030 Bacterial infectious shock Hla toxin
TNM039 Rabies prevention Rabies virus
Product code Indications Target Pre-clinical phase I phase 2 phase 3 Registration
TNM001 Prevention of RSV infection RSV Pre-F protein
TNM002 Prevention of tetanus Tetanus toxin
TNM005 Prevention and treatment of VZV infection VZV gH/gL protein
TNM006 hCMV infection (prevention) human cytomegalovirus
TNM009 Pain NGF
TNM030 Bacterial infectious shock Hla toxin
TNM039 Rabies prevention Rabies virus